Bioactive Products
| A unique collection of 184 natural compounds used for Antibacterial research. | ||
| Catalog No: | Bb192 | Antibacterial Compound Library Screening Details |
| Size: | 1mg/well * 184 Compounds 2mg/well * 184 Compounds | |
| Cat. No. | Information |
| CFN90975 | Sodium houttuyfonate Sodium houttuyfonate is anti-pseudomonas agents, inhibits virulence related motility of Pseudomonas aeruginosa.It also inhibits biofilm formation and alginate biosynthesis-associated gene expression in a clinical strain of Pseudomonas aeruginosa in vitro. Sodium houttuyfonate has anti-inflammatory activity, inhibits inflammation by blocking the MAPKs/NF-κB signaling pathways in bovine endometrial epithelial cells. |
| CFN93010 | Thymol Thymol is a positive allosteric modulator of human GABAA receptors and a homo-oligomeric GABA receptor from Drosophila melanogaster, which has antioxidant, antimicrobial, anti-inflammatory, insecticidal and repellent properties. Thymol possesses anti-hepatotoxic activity, it prevents the CCl4-induced prolongation in pentobarbital sleeping time confirming hepatoprotectivity.Thymol has inhibitory effect on the release of human neutrophil elastase. |
| CFN93995 | Hinokitiol Hinokitiol has antibacterial effect , it can inhibit all Staphylococcus aureus isolates with MICs of 1.56-3.13 mg/L, it also has antifungal activity against 51 Malassezia pachydermatis strains, it is an inexpensive and safe treatment with anti-inflammatory and deodorant effects that can be recommended as an effective remedy for canine otitis externa. beta-thujaplicin (Hinokitiol) has ability to extract mitochondrial Mg and the prevention of the effects of beta-thujaplicin by an excess of Mg in the medium, suggests a common mode of action of beta-thujaplicin as a lipophilic chelator of Mg and other divalent cations. |
| CFN90813 | Juncusol Juncusol shows anxiolytic and sedative activities, it shows anxiolytic activity at dosages of 10 mg/kg; it can induce caspase-3-mediated cytotoxicity in HT22 cells. Juncusol has anti-microbial activity, it shows significant activity against MRSA strains. |
| CFN90814 | Dehydroeffusol Dehydroeffusol possesses anti-cancer, anxiolytic and sedative properties, it may antagonize the spasmogenic activity of various agents, and therefore, could be a promising agent in the treatment of spasms. Dehydroeffusol displays enhanced antimicrobial activities in light, its antimicrobial activities (minimum inhibitory concentrations) against methicillin-resistant and -sensitive Staphylococcus aureus and Candida albicans are increased 16 fold by irradiation with ultraviolet A (UVA). |
